Myriad Genetics, Inc. (LON:0K3W)
London · Delayed Price · Currency is GBP · Price in USD 7.24
-0.05 (-0.75%)
At close: Dec 5, 2025
Myriad Genetics Market Cap
Myriad Genetics has a market cap or net worth of 496.03 million as of December 5, 2025. Its market cap has decreased by -53.96% in one year.
Market Cap
496.03M
Enterprise Value
546.25M
Revenue
613.97M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.24
Market Cap Chart
Since October 6, 1995, Myriad Genetics's market cap has increased from 110.60M to 496.03M, an increase of 348.49%. That is a compound annual growth rate of 5.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 496.03M | -50.24% |
| Dec 31, 2024 | 996.94M | -25.18% |
| Dec 29, 2023 | 1.33B | 36.53% |
| Dec 30, 2022 | 975.86M | -40.05% |
| Dec 31, 2021 | 1.63B | 49.42% |
| Dec 31, 2020 | 1.09B | -28.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 209.56B |
| GSK plc | 73.29B |
| Haleon | 32.02B |
| Smith & Nephew | 10.44B |
| Convatec Group | 4.45B |
| Hikma Pharmaceuticals | 3.52B |
| HUTCHMED (China) | 1.84B |
| Genus | 1.77B |